Although the role of KLF4 in AML is controversially discussed, it has been shown to play an oncogenic role in AML cell lines and the deletion of KLF4 by CRISPR/Cas9 suppresses cell growth and induces apoptosis [34]. Here, KLF4 is linked to acute myeloid leukemia.